Renaissance Technologies’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,800
Closed -$4.11M 3669
2024
Q2
$4.11M Buy
+12,800
New +$4.16M 0.01% 1432
2023
Q4
Sell
-21,300
Closed -$5.24M 3869
2023
Q3
$5.24M Buy
+21,300
New +$5.83M 0.01% 1278
2022
Q3
Sell
-323,513
Closed -$54.4M 4172
2022
Q2
$54.4M Buy
323,513
+215,513
+200% +$46.3M 0.06% 340
2022
Q1
$27.1M Sell
108,000
-209,400
-66% -$52.6M 0.03% 595
2021
Q4
$81.5M Buy
+317,400
New +$77.7M 0.1% 216
2020
Q3
Sell
-977,400
Closed -$94.9M 3486
2020
Q2
$94.9M Buy
977,400
+427,500
+78% +$44.4M 0.08% 261
2020
Q1
$49.4M Buy
549,900
+392,800
+250% +$50.9M 0.05% 393
2019
Q4
$23.2M Sell
157,100
-32,800
-17% -$4.4M 0.02% 927
2019
Q3
$22.9M Sell
189,900
-218,900
-54% -$28.3M 0.02% 887
2019
Q2
$55.3M Sell
408,800
-445,000
-52% -$56.3M 0.05% 453
2019
Q1
$111M Buy
853,800
+647,600
+314% +$87M 0.1% 233
2018
Q4
$25.7M Sell
206,200
-261,900
-56% -$35.2M 0.03% 746
2018
Q3
$65.1M Sell
468,100
-626,331
-57% -$78M 0.07% 345
2018
Q2
$112M Buy
1,094,431
+714,331
+188% +$72.3M 0.12% 168
2018
Q1
$36.9M Buy
+380,100
New +$36.9M 0.04% 574
2017
Q3
Sell
-642,700
Closed -$56M 3261
2017
Q2
$56M Buy
642,700
+360,600
+128% +$30.5M 0.07% 341
2017
Q1
$25.1M Buy
+282,100
New +$23.5M 0.04% 669
2016
Q4
Sell
-45,100
Closed -$3.41M 3329
2016
Q3
$3.41M Sell
45,100
-529,400
-92% -$40.5M 0.01% 1857
2016
Q2
$44.2M Buy
+574,500
New +$45.4M 0.08% 301
2016
Q1
Sell
-262,500
Closed -$17.8M 3428
2015
Q4
$17.8M Sell
262,500
-253,900
-49% -$17.7M 0.04% 622
2015
Q3
$39.9M Buy
516,400
+452,300
+706% +$40M 0.1% 242
2015
Q2
$5.82M Buy
+64,100
New +$5.14M 0.01% 1341
2015
Q1
Sell
-382,900
Closed -$28.1M 3237
2014
Q4
$28.1M Buy
+382,900
New +$26.9M 0.07% 340
2014
Q3
Sell
-416,000
Closed -$23.5M 2849
2014
Q2
$23.5M Buy
+416,000
New +$21.9M 0.05% 395
2013
Q3
Sell
-428,900
Closed -$15.5M 2864
2013
Q2
$15.5M Buy
+428,900
New +$16.6M 0.04% 546

Other funds holding HCA

Renaissance Technologies's HCA Position: Q3 2024 in Review

Renaissance Technologies sold out of HCA Healthcare (HCA) in Q3 2024, closing a stake of 12,800 shares — an estimated $4.11M sold.

Renaissance Technologies first reported a position in HCA in Q2 2013 and held it in 25 quarters. The position peaked at $112M in Q2 2018. 1,203 funds tracked by Wall St. Rank hold HCA as of Q3 2024.

  • Renaissance Technologies reported no remaining HCA Healthcare position as of Q3 2024 after selling out during the quarter.
  • Renaissance Technologies sold 12,800 HCA Healthcare shares in Q3 2024, an estimated $4.11M.
  • Renaissance Technologies first reported a position in HCA Healthcare in Q2 2013 and held it in 25 quarters.
  • Renaissance Technologies's HCA Healthcare position peaked at $112M in Q2 2018.
  • 1,203 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.

Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.